VC  Avalon Ventures

http://www.avalon-ventures.com





     Office Locations:

55 Cambridge Parkway, Suite 103
Cambridge, MA 02142
Phone: 858-348-2180
Fax: 858-348-2183

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Communications & Networking
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Avalon Ventures is a San Diego and Boston-based venture capital fund, currently investing Avalon Ventures VIII, LP, which has $150 million under management. The fund primarily focuses on seed and early development stage companies in the wireless communications, Web 3.0 digital media, and life science industries. The firm has a geographic investment focus on companies based in California and the Northeast. Avalon does co-invest in certain circumstances with firms such as Kleiner Perkins Caufield & Byers (12 deals) and Versant Ventures (11 deals).


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Southern California Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Branden M. Bohrmann Managing Member
    Court Turner Venture Partner
    Douglas J. Downs Managing Member and Chief Financial Officer
    Jay B. Lichter Ph.D Managing Member
    Kevin J. Kinsella Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      11/20/2024


      Valora Therapeutics


      CA


      $30,000,000


      Seed


     

    Portfolio companies include:


      Adrenergics


      AeroFS
        web link


      Ankasa Regenerative Therapeutics


      AristaMD


      Avelas Biosciences
        web link


      Averon
        web link


      Backupify
        web link


      BookBub
        web link


      CadheRx Therapeutics


      Calporta Therapeutics


      Cloudant


      Fortis Therapeutics


      Happy Cloud
        web link


      Indix
        web link


      Janux Therapeutics
        web link


      Jnana Therapeutics
        web link


      Kaltura


      Kinvey
        web link


      LoopIt
        web link


      MOGL


      Nanigans
        web link


      Orion Labs
        web link


      Otonomy
        web link


      Pando
        web link


      Pingup
        web link


      Pronoun
        web link


      Proximal Data
        web link


      SideCar Technologies
        web link


      Silarus Therapeutics
        web link


      Simulmedia
        web link


      Sitari Pharmaceuticals
        web link


      Smyte
        web link


      Synthorx
        web link


      Talla


      Tapad
        web link


      Teambox
        web link


      Thyritope Biosciences
        web link


      Valora Therapeutics
        web link


     

    Recent News: